China’s first ZEISS ARTEVO 850 navigation-guided ICL V5 surgery completed by Dr. Xiao Qirui in Shanghai receives media coverage
In May 2026, Dr. Xiao Qirui completed China’s first ZEISS ARTEVO 850 navigation-guided ICL V5 surgery in Shanghai, receiving coverage from multiple media outlets including Xinmin Evening News, China.com, Phoenix News, Eastday, Shanghai Observer, Shanghai Changning and East Money.
First national case receives broad media attention
In May 2026, Dr. Xiao Qirui, director of the refractive department at Shanghai University Affiliated Eye Hospital, completed China’s first ZEISS ARTEVO 850 navigation-guided ICL V5 spectacle-independence surgery. The successful procedure marked a new stage for myopia refractive correction in China, supported by digital navigation and full-process ultra-clear visualization, and set a new clinical benchmark for minimally invasive precision refractive care.
The completion of the procedure was reported by multiple official and mainstream media outlets in China, including Xinmin Evening News, China.com, Phoenix News, Eastday, Shanghai Observer, the Shanghai Changning public account and East Money.
Media coverage screenshots
The screenshots below are organized by media platform and present the coverage received by this first national ZEISS ARTEVO 850 navigation-guided ICL V5 surgery.
